Christopher Murawsky
8Patents
3h-index
32Co-inventors
49Inventor score
Filing activity: Dec 21, 2016 → May 27, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10294303B2 | Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists | Chemistry; Metallurgy | 7 | Active |
| US11530274B2 | Anti-STEAP1 antigen-binding protein | Chemistry; Metallurgy | 4 | Active |
| US11046774B2 | Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists | Chemistry; Metallurgy | 3 | Active |
| US11066472B2 | Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof | Chemistry; Metallurgy | 2 | Active |
| US12012462B2 | Chimeric receptors to DLL3 and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12331122B2 | Anti-ASGR-1 monoclonal inhibitory antibodies | Chemistry; Metallurgy | 0 | Active |
| US12060430B2 | Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR) | General | 0 | Revoked |
| US12252540B2 | Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.